2026-08-04 Shionogi & Co.,Ltd. “We have posted the transcript of our Q1 2026 earnings presentation.”
2026-08-04 Shionogi & Co.,Ltd. “We have posted the transcript of our Q1 2026 earnings presentation. … 続きを読む
Shionogi & Co.,Ltd.
2026-08-03 Shionogi & Co.,Ltd. “We have posted our financial results summary and supplementary materials for the first quarter of fiscal year 2026.”
2026-08-03 Shionogi & Co.,Ltd. “We have posted our financial results summary and supplementary mate … 続きを読む
2026-08-03 Shionogi & Co.,Ltd. “We have posted the financial results presentation materials for the first quarter of fiscal year 2026.”
2026-08-03 Shionogi & Co.,Ltd. “We have posted the financial results presentation materials for the … 続きを読む
2026-07-30 Shionogi & Co.,Ltd. “Regarding ViiV's announcement about the VOGUE trial of the anti-HIV drug Dovato.”
2026-07-30 Shionogi & Co.,Ltd. “Regarding ViiV's announcement about the VOGUE trial of the anti … 続きを読む
2026-07-30 Shionogi & Co.,Ltd. “Regarding the announcement of new data from ViiV regarding its long-acting injectable formulation.”
2026-07-30 Shionogi & Co.,Ltd. “Regarding the announcement of new data from ViiV regarding its long … 続きを読む
2026-07-30 Shionogi & Co.,Ltd. “Regarding support for victims of the 2026 Kumamoto Earthquake.”
2026-07-30 Shionogi & Co.,Ltd. “Regarding support for victims of the 2026 Kumamoto Earthquake.̶ … 続きを読む
2026-07-29 Shionogi & Co.,Ltd. “Regarding the launch of the anti-coronavirus (SARS-CoV-2) drug encitrelvir fumarate (XOCOVA®) in the United States.”
2026-07-29 Shionogi & Co.,Ltd. “Regarding the launch of the anti-coronavirus (SARS-CoV-2) drug enci … 続きを読む
2026-07-24 Shionogi & Co.,Ltd. “The efficacy of baloxavir and resistance-related mutations against highly pathogenic avian influenza A(H7N9) were evaluated.”
2026-07-24 Shionogi & Co.,Ltd. “The efficacy of baloxavir and resistance-related mutations against … 続きを読む
2026-07-23 Shionogi & Co.,Ltd. “Regarding the completion of payment for the disposal of treasury stock as restricted stock compensation.”
2026-07-23 Shionogi & Co.,Ltd. “Regarding the completion of payment for the disposal of treasury st … 続きを読む
2026-07-23 Shionogi & Co.,Ltd. “Regarding Torii Pharmaceutical's announcement concerning the transfer of manufacturing and marketing approval for the topical corticosteroid preparations "Locoid® Ointment 0.1%" and "Locoid® Cream 0.1%".”
2026-07-23 Shionogi & Co.,Ltd. “Regarding Torii Pharmaceutical's announcement concerning the tr … 続きを読む